SeQure DX
Business Services · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1440 Main St Ste 320, Waltham, Massachus...Phone Number
(978) 828-1395Website
www.sequre-dx.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About SeQure DX
SeQure DX specializes in risk assessment services for cell and gene therapy development, focusing on off-target analysis to enhance patient safety and regulatory success. They provide a comprehensive suite of assays including screening, nomination, and confirmation assays designed to ensure precise editing confirmation and thorough risk assessment. Their primary clients include developers in the cell gene therapy, bioprocessing, and translational research sectors, who benefit from data-driven decision-making to reduce costs and accelerate therapy development. Committed to advancing precision medicine, SeQure DX aims to transform healthcare by empowering safe and effective gene-edited therapies.Explore more
SeQure DX Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is SeQure DX your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on SeQure DX recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at SeQure DX
Website visits: Recent activity has been detected on your website
Click to see if SeQure DX had a recent Job posting/layoffs
SeQure DX, which may be a good buyer, showed buying intent in Masked Content Topic
Check if SeQure DX has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if SeQure DX is spiking on competitors!
Product Launch: Get notified when SeQure DX launches new products
Funding: Get notified immidiatlly once SeQure DX has new funding data
Recommended Actions
Find VP level buyers at SeQure DX
Find 3 more new buyers
Compare Similar Companies to SeQure DX
Compare insights from companies similar to SeQure DX, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
SeQure DX is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
SeQure DX is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about SeQure DX.
SeQure DX Tech Stack
A closer look at the technologies used by SeQure DX
SeQure DX News & Media
MaxCyte® Acquires SeQure Dx to Broaden Cell Engineering Offerings with On-target and Off-target Editing Assessments
ROCKVILLE, Md., Jan. 30, 2025 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing solutions to advance the discovery, development and commercialization of next-generation cell therapeutics announced today the acquisition of SeQure Dx, a market leader of on-target and off-target editing assessment services for cell and gene therapies.Integrated DNA Technologies Announces New Licensing Agreement with SeQure Dx to Advance CRISPR-based Therapeutics
CORALVILLE, Iowa & WALTHAM, Mass.--(BUSINESS WIRE)-- #CGMP--IDT inks licensing agreement with SeQure Dx to support cell and gene therapy developers through all stages of their CRISPR-based therapeutic programs.Synthego and SeQure Dx Partner to Provide Comprehensive Off-Target Analysis Services for CRISPR-Based Therapeutics Developers
REDWOOD CITY, Calif. and WALTHAM, Mass., Jan. 23, 2024 /PRNewswire/ -- Synthego, a leading provider of genome engineering solutions, and SeQure Dx, a company focused on off-target analysis for preclinical and clinical gene modification customers, have announced a strategic partnership to...
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding SeQure DX
Sign Up For FreeTo access detailed company insights
SeQure DX specializes in risk assessment services for cell and gene therapy development, focusing on off-target analysis to enhance patient safety and regulatory success. They provide a comprehensive suite of assays including screening, nomination, and confirmation assays designed to ensure precise editing confirmation and thorough risk assessment.... Read More
